François Boller Book order

As the human hypothalamus has traditionally been considered part of the neuroendocrine system, it has been of little interest to neurologists. This volume creates renewed interest in the subject, highlighting groundbreaking research that links this complex part of the human brain to a variety of neurological and psychological disorders.Clinicians, researchers, and practitioners from a variety of medical fields will find this to be a comprehensive presentation of new research that applies to a variety of disorders, including their origin, diagnosis, and treatment. From groundbreaking discussions that link the human hypothalamus to attention deficits in the dementias, to its role in disorders such as narcolepsy and certain epilepsies, users will find this volume to be an invaluable resource for research and patient care.Specific information on topics including depression, eating disorders, aggression, and mental retardation are included, giving those in the field of neurology, psychiatry, endocrinology, and pediatrics a comprehensive understanding on how the human hypothalamus is related to patient disorders in these fields. * A comprehensive accounting of groundbreaking new research regarding the human hypothalamus * New insights on the hypothalamus and its role in disorders, including dementias, epilepsies, and associated psychiatric diseases* A greater understanding of how the human hypothalamus impacts research and treatment protocols in a variety of fields, including neurology, endocrinology, and psychology

This volume presents the proceedings of the symposium held in Toulouse on April 24, 1989, on the topic "Biological Markers of Alzheimer's Disease. " This sym posium was the fourth of a continuing and successful series of Colloques Medecine et Recherche organized by the Fondation IPSEN pour la Recherche Therapeutique, addressing various aspects of contemporary research in the field of Alzheimer's disease (AD). The series started in September 1987 with "Im munology and Alzheimer's Disease," followed 6 months later in Paris by "Gene tics and Alzheimer's Disease" and in September 1988 in Montpellier by "Neuronal Grafting and Alzheimer's Disease. " The present symposium was organized for the purpose of gathering the most current ideas concerning biological markers of AD. The papers presented at this symposium may be roughly subdivided into three groups. The first deals with the markers of AD at the level of the brain itself. These markers are studied either through the cerebrospinal fluid or through techniques such as nuclear magnetic resonance (NMR) - approaches which respectively aim at demonstrating the cerebral changes indicated by the debris resulting from the disease, or studying the possible neurochemical abnormalities that occur in the earlier stages of AD.